Institutional Ownership Allogene Therapeutics, Inc. (ALLO)
This table provides information about the institutional ownership of Allogene Therapeutics, Inc. (ALLO). We have compiled data on the 169 institutions that hold shares in the stock, with a total of 131 Million shares, which have been reported (via 13F filing form) to have a value of $183 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Tpg Gp A, LLC
Fort Worth, TX |
Nov 14, 2024 Q3 2024 |
18,716,306
shares
|
$26.8 Million
1.25% of portfolio
|
Q4 2021
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
16,445,682
shares
|
$23.5 Million
0.0% of portfolio
|
Q2 2024
Added 70.37%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
8,000,692
shares
|
$11.4 Million
0.0% of portfolio
|
Q4 2024
Reduced 3.93%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
7,013,083
shares
|
$10 Million
0.0% of portfolio
|
Q3 2024
Reduced 8.54%
|
|
|
Capital World Investors
Los Angeles, CA |
Feb 13, 2025 Q4 2024 |
6,896,552
shares
|
$9.86 Million
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Lynx1 Capital Management LP
San Juan, PR |
Nov 14, 2024 Q3 2024 |
6,202,374
shares
|
$8.87 Million
6.22% of portfolio
|
Q3 2024
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
5,039,594
shares
|
$7.21 Million
0.0% of portfolio
|
Q3 2024
Added 105.99%
|
|
|
Primecap Management CO
Pasadena, CA |
Feb 10, 2025 Q4 2024 |
4,927,340
shares
|
$7.05 Million
0.01% of portfolio
|
Q4 2024
Reduced 13.07%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
4,838,743
shares
|
$6.92 Million
0.0% of portfolio
|
Q3 2024
Reduced 16.44%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
4,364,300
shares
|
$6.24 Million
0.11% of portfolio
|
Q3 2024
Added 0.12%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
3,736,132
shares
|
$5.34 Million
0.0% of portfolio
|
Q4 2024
Reduced 8.6%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
3,561,626
shares
|
$5.09 Million
0.0% of portfolio
|
Q4 2024
Added 30.44%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
3,232,618
shares
|
$4.62 Million
0.0% of portfolio
|
Q4 2024
Added 0.17%
|
|
|
Wildcat Capital Management, LLC
|
Jan 29, 2025 Q4 2024 |
2,920,787
shares
|
$4.18 Million
2.46% of portfolio
|
Q2 2024
Added 52.06%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 15, 2024 Q3 2024 |
2,867,750
shares
|
$4.1 Million
0.43% of portfolio
|
Q1 2024
New holding
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
2,797,970
shares
|
$4 Million
0.02% of portfolio
|
Q3 2024
Reduced 5.5%
|
|
|
Perceptive Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
2,725,000
shares
|
$3.9 Million
0.2% of portfolio
|
Q2 2024
New holding
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
2,410,400
shares
|
$3.45 Million
0.02% of portfolio
|
Q3 2024
Added 7.49%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
2,106,577
shares
|
$3.01 Million
0.0% of portfolio
|
Q4 2024
Reduced 2.59%
|
|
|
Vida Ventures Advisors, LLC
|
Jan 21, 2025 Q4 2024 |
1,798,163
shares
|
$2.57 Million
4.68% of portfolio
|
Q3 2020
New holding
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
1,721,530
shares
|
$2.46 Million
0.0% of portfolio
|
Q3 2024
Reduced 20.19%
|
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,500,000
shares
|
$2.15 Million
0.32% of portfolio
|
Q3 2024
Reduced 31.82%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
1,248,539
shares
|
$1.79 Million
0.0% of portfolio
|
Q3 2024
Added 20.27%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
1,188,838
shares
|
$1.7 Million
0.0% of portfolio
|
Q4 2024
Added 0.85%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Nov 14, 2024 Q3 2024 |
1,050,118
shares
|
$1.5 Million
0.76% of portfolio
|
Q3 2024
Added 73.54%
|